153 related articles for article (PubMed ID: 6370072)
1. Tuftsin, a natural activator of phagocyte cells: an overview.
Najjar VA
Ann N Y Acad Sci; 1983; 419():1-11. PubMed ID: 6370072
[TBL] [Abstract][Full Text] [Related]
2. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
[TBL] [Abstract][Full Text] [Related]
3. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.
Najjar VA
Klin Wochenschr; 1979 Aug; 57(15):751-6. PubMed ID: 385971
[TBL] [Abstract][Full Text] [Related]
4. Biochemical aspects of tuftsin deficiency syndrome.
Najjar VA
Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
[TBL] [Abstract][Full Text] [Related]
5. The function of tuftsin and similar sequences in other proteins.
Segal S; Tzehoval E; Feldman M
Ann N Y Acad Sci; 1983; 419():168-76. PubMed ID: 6324635
[No Abstract] [Full Text] [Related]
6. Tuftsin: its chemistry, biology, and clinical potential.
Fridkin M; Najjar VA
Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
[TBL] [Abstract][Full Text] [Related]
7. Biological and biochemical characteristics of the tetrapeptide tuftsin, Thr-Lys-Pro-Arg.
Najjar VA
Adv Exp Med Biol; 1979; 121(A):131-47. PubMed ID: 398141
[No Abstract] [Full Text] [Related]
8. [Tuftsin--new analogues and properties].
Wardowska A; Dzierzbicka K; Myśliwski A
Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
[TBL] [Abstract][Full Text] [Related]
9. Cytophilic gamma-globulin and tuftsin.
Najjar VA
Surv Immunol Res; 1982; 1(1):9-16. PubMed ID: 6195710
[No Abstract] [Full Text] [Related]
10. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
Fridkin M; Gottlieb P
Mol Cell Biochem; 1981 Dec; 41():73-97. PubMed ID: 7035869
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
Najjar VA
Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
[TBL] [Abstract][Full Text] [Related]
12. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
Bump NJ; Najjar VA
Mol Cell Biochem; 1984 Sep; 63(2):137-42. PubMed ID: 6493218
[TBL] [Abstract][Full Text] [Related]
13. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of tuftsin.
Nishioka K; Babcock GF; Phillips JH; Noyes RD
Mol Cell Biochem; 1981 Dec; 41():13-8. PubMed ID: 6895773
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of tuftsin.
Martinez J; Winternitz F
Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
[TBL] [Abstract][Full Text] [Related]
16. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
Phillips JH; Babcock GF; Nishioka K
J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
[TBL] [Abstract][Full Text] [Related]
17. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
[TBL] [Abstract][Full Text] [Related]
18. The generation of antibody in mice to tuftsin: a naturally occurring phagocytosis stimulating tetrapeptide.
Naim JO; van Oss CJ
Immunol Invest; 1991 Jul; 20(4):351-64. PubMed ID: 1937582
[TBL] [Abstract][Full Text] [Related]
19. Immunopharmacological properties of tuftsin and of some analogues.
Florentin I; Martinez J; Maral J; Pelletier M; Chung V; Roch-Arveiller M; Bruley-Rosset M; Giroud JP; Winternitz F; Mathé G
Ann N Y Acad Sci; 1983; 419():177-91. PubMed ID: 6424534
[No Abstract] [Full Text] [Related]
20. The effect of anti-tuftsin antibody on the phagocytosis of bacteria by human neutrophils.
Naim JO; Lanzafame RJ; van Oss CJ
Immunol Invest; 1991; 20(5-6):499-506. PubMed ID: 1791037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
